GB9828548D0 - Method - Google Patents

Method

Info

Publication number
GB9828548D0
GB9828548D0 GBGB9828548.9A GB9828548A GB9828548D0 GB 9828548 D0 GB9828548 D0 GB 9828548D0 GB 9828548 A GB9828548 A GB 9828548A GB 9828548 D0 GB9828548 D0 GB 9828548D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828548.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIRAL AS A
Original Assignee
VIRAL AS A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIRAL AS A filed Critical VIRAL AS A
Priority to GBGB9828548.9A priority Critical patent/GB9828548D0/en
Publication of GB9828548D0 publication Critical patent/GB9828548D0/en
Priority to CA002352423A priority patent/CA2352423A1/en
Priority to AU18793/00A priority patent/AU1879300A/en
Priority to EP99962435A priority patent/EP1140075A1/en
Priority to JP2000590633A priority patent/JP2002533392A/en
Priority to PCT/GB1999/004392 priority patent/WO2000038679A1/en
Priority to ZA200104402A priority patent/ZA200104402B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
GBGB9828548.9A 1998-12-23 1998-12-23 Method Ceased GB9828548D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9828548.9A GB9828548D0 (en) 1998-12-23 1998-12-23 Method
CA002352423A CA2352423A1 (en) 1998-12-23 1999-12-23 Treatment of retroviral infections with oxyphenbutazone
AU18793/00A AU1879300A (en) 1998-12-23 1999-12-23 Treatment of retroviral infections with oxyphenbutazone
EP99962435A EP1140075A1 (en) 1998-12-23 1999-12-23 Treatment of retroviral infections with oxyphenbutazone
JP2000590633A JP2002533392A (en) 1998-12-23 1999-12-23 Treatment of retroviral infections with oxyphenbutazone
PCT/GB1999/004392 WO2000038679A1 (en) 1998-12-23 1999-12-23 Treatment of retroviral infections with oxyphenbutazone
ZA200104402A ZA200104402B (en) 1998-12-23 2001-05-29 Treatment of retroviral infections with oxyphenbutazone.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828548.9A GB9828548D0 (en) 1998-12-23 1998-12-23 Method

Publications (1)

Publication Number Publication Date
GB9828548D0 true GB9828548D0 (en) 1999-02-17

Family

ID=10844977

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828548.9A Ceased GB9828548D0 (en) 1998-12-23 1998-12-23 Method

Country Status (7)

Country Link
EP (1) EP1140075A1 (en)
JP (1) JP2002533392A (en)
AU (1) AU1879300A (en)
CA (1) CA2352423A1 (en)
GB (1) GB9828548D0 (en)
WO (1) WO2000038679A1 (en)
ZA (1) ZA200104402B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117232A (en) * 1976-03-08 1978-09-26 Interx Research Corporation Transient pro-drug forms of phenylbutazone
FR2593703B1 (en) * 1986-02-04 1990-07-20 Miesch Jean Olivier APPLICATION OF BUTYL-4-DIPHENYL-1,2-PYRAZOLIDINE-DIONE-3,5 AS ANTIVIRAL AGENT IN HUMANS OR ANIMALS

Also Published As

Publication number Publication date
JP2002533392A (en) 2002-10-08
AU1879300A (en) 2000-07-31
EP1140075A1 (en) 2001-10-10
CA2352423A1 (en) 2000-07-06
WO2000038679A1 (en) 2000-07-06
ZA200104402B (en) 2002-05-29

Similar Documents

Publication Publication Date Title
GB9809414D0 (en) Method
GB9809776D0 (en) Method
GB9819764D0 (en) Method
GB9814055D0 (en) Method
GB9810722D0 (en) Method
GB9817266D0 (en) Method
GB9819769D0 (en) Method
GB9802475D0 (en) Method
GB9926144D0 (en) Method
GB9820185D0 (en) Method
GB9821225D0 (en) Method
GB9809780D0 (en) Method
GB9809782D0 (en) Method
GB9821038D0 (en) Method
GB9904241D0 (en) Method
GB9825374D0 (en) Method
GB9823963D0 (en) Method
GB9811185D0 (en) Method
GB9801272D0 (en) Method
GB9813126D0 (en) Method
GB9801271D0 (en) Method
GB9802207D0 (en) Method
GB9816819D0 (en) Method
PL325072A1 (en) Mwechanical nap-forming method
GB9818237D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)